Zohara Aghai Selected Research

HA-1 antigen

3/2009	Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.
9/2008	Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zohara Aghai Research Topics

Disease

4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2015 - 09/2008
3	Leukemia 01/2015 - 10/2010
2	Neoplasms (Cancer) 03/2009 - 09/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015

Drug/Important Bio-Agent (IBA)

3	Minor Histocompatibility AntigensIBA 01/2015 - 09/2008
2	HA-1 antigenIBA 03/2009 - 09/2008
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2009 - 09/2008
1	AntigensIBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Peptides (Polypeptides)IBA 10/2010
1	Decitabine FDA Link 03/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2008

Therapy/Procedure

4	Stem Cell Transplantation 01/2015 - 09/2008
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2016
1	Cell Transplantation 06/2011
1	Immunotherapy 03/2009